Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
July 2016 onwards
Submit An Event
Events - March 2014
Lab-on-a-Chip European Congress
10 Mar 2014 - 11 Mar 2014 - Berlin, Germany
This congress will bring together leaders from both academia and industry to discuss innovative developments in this exciting field. Attention will also be given to some of the many applications of Labs-on-Chips, from the enhancement of life science research, to taking diagnostics to the point of need. Overall this track will provide an excellent snapshot of this rapidly growing field.
• Diagnostics and Medical Applications
• Droplet-based Microfluidics
• Market Orientated Device Development
• Point-of-care Devices and Diagnostics
• Single Cell Analysis
Planned round table discussions on key areas are sure to energize the participants in defining the Lab-on-a-Chip landscape. Open to all conference and exhibition attendees, these discussions will provide an excellent opportunity to exchange ideas and network.
Reasons to attend:
• Exchange ideas and expand your network with leading professionals in this field
• This conference will bring together top international scientists and clinicians presenting cutting-edge discoveries
• The latest Lab-on-a-Chip technologies and applications will be presented
• Up-to-date research in the fields of Optofluidics and Nanotechnology
• The conference will feature an extensive exhibition and poster session
• Round table discussions open to all attendees will engage networking and discussion
The conference will be co-located with Advances in Biodetection & Biosensors, Single Cell Analysis Europe and Advances in Microarray Technology . Registered delegates will have unrestricted access to all co-located meetings ensuring a comprehensive learning and sharing experience, as well as being financially beneficial for attendees. Running alongside Lab-on-a-Chip European Congress will be an exhibition covering the latest technological advances and associated services within these fields.
Deadline is 10 February 2014
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!